Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

thinkemotive

- PMLiVE

Boehringer starts to feel impact of Spiriva generics

Asthma and COPD therapy facing increasing competition in ‘crowded’ market category

NHiS appoints mental health associate director

Laurence Mascarenhas joins the Commissioning Excellence division

Amgen finance VP joins True North Therapeutics

Pamela Wapnick appointed as chief financial officer

- PMLiVE

From push to pull: what makes effective multichannel marketing?

How designing CME becomes a listen and learn exercise as physicians are adapting to social media

Biogen Idec building

Biogen buys into Ionis’ nusinersen after positive phase III trial

Potential blockbuster spinal muscular atrophy drug will be filed “in the coming months” 

- PMLiVE

From two final medical signatories to one

Is the UK pharma industry ready for this switch?

- PMLiVE

Pfizer buys gene therapy specialist Bamboo

Expands pipeline with Duchenne muscular dystrophy candidate in deal worth $700m

- PMLiVE

Editas Medicine adds to board of directors

Alnylam Pharmaceuticals’ Dr Akshay Vaishnaw joins

- PMLiVE

GSK and Google launch bioelectronics venture

Will develop electronic implants to treat chronic diseases, including diabetes

- PMLiVE

Dept of Health to launch sepsis awareness campaign across UK

Aims to transform public understanding and NHS handling of the condition

- PMLiVE

AZ feels Crestor sting but new products provide some relief

Tagrisso and Lynparza boost sales while a string of new cancer studies are in the pipeline

- PMLiVE

Rare blood cancer therapy Oncaspar gets NICE green light

Baxalta’s acute lymphoblastic leukaemia treatment recommended for NHS use

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links